Literature DB >> 1330688

Stable expression of human D3 dopamine receptors in GH4C1 pituitary cells.

G R Seabrook1, S Patel, R Marwood, F Emms, M R Knowles, S B Freedman, G McAllister.   

Abstract

Human D3 dopamine receptor DNA was stably transfected into GH4C1 pituitary cells. Displacement of iodosulpiride binding in hD3 transfected cells (Kd = 0.3 nM, Bmax = 89 fmol/mg protein) by dopaminergic ligands was indistinguishable from that of hD3 receptors in CHO cells. Only two clonal cell lines exhibited weak GppNHp-dependent shifts in [3H]N-0437 binding, and these were used for functional assays. Neither arachidonic acid metabolism, cAMP levels, inositol phosphate turnover, intracellular calcium, or potassium currents were consistently affected by dopamine (1-10 microM). The paucity of responses indicates that human D3 receptors do not couple efficiently to these second messengers in GH4C1 cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1330688     DOI: 10.1016/0014-5793(92)80918-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

Review 1.  Advances and challenges in the search for D2 and D3 dopamine receptor-selective compounds.

Authors:  Amy E Moritz; R Benjamin Free; David R Sibley
Journal:  Cell Signal       Date:  2017-07-14       Impact factor: 4.315

2.  Antipsychotics with inverse agonist activity at the dopamine D3 receptor.

Authors:  N Griffon; C Pilon; F Sautel; J C Schwartz; P Sokoloff
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

3.  Upregulation of (+)-7-hydroxy-N,N-di-n-[3H]propyl-2-aminotetralin binding following intracerebroventricular administration of a nitric oxide generator.

Authors:  D R Wallace; R M Booze
Journal:  Neurochem Res       Date:  1997-02       Impact factor: 3.996

4.  Dynamic changes in striatal dopamine D2 and D3 receptor protein and mRNA in response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) denervation in baboons.

Authors:  R D Todd; J Carl; S Harmon; K L O'Malley; J S Perlmutter
Journal:  J Neurosci       Date:  1996-12-01       Impact factor: 6.167

5.  Efficient functional coupling of the human D3 dopamine receptor to G(o) subtype of G proteins in SH-SY5Y cells.

Authors:  P G Zaworski; G L Alberts; J F Pregenzer; W B Im; J L Slightom; G S Gill
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

6.  The antipsychotics olanzapine, risperidone, clozapine, and haloperidol are D2-selective ex vivo but not in vitro.

Authors:  Patrick N McCormick; Shitij Kapur; Ariel Graff-Guerrero; Roger Raymond; José N Nobrega; Alan A Wilson
Journal:  Neuropsychopharmacology       Date:  2010-04-21       Impact factor: 7.853

7.  Depression of high-threshold calcium currents by activation of human D2 (short) dopamine receptors expressed in differentiated NG108-15 cells.

Authors:  G R Seabrook; G McAllister; M R Knowles; J Myers; H Sinclair; S Patel; S B Freedman; J A Kemp
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

8.  Pharmacology of high-threshold calcium currents in GH4C1 pituitary cells and their regulation by activation of human D2 and D4 dopamine receptors.

Authors:  G R Seabrook; M Knowles; N Brown; J Myers; H Sinclair; S Patel; S B Freedman; G McAllister
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

9.  S-(+)-aporphines are not selective for human D3 dopamine receptors.

Authors:  N S Kula; R J Baldessarini; J W Kebabian; J L Neumeyer
Journal:  Cell Mol Neurobiol       Date:  1994-04       Impact factor: 5.046

10.  Functional expression of human D3 dopamine receptors in differentiated neuroblastoma x glioma NG108-15 cells.

Authors:  G R Seabrook; J A Kemp; S B Freedman; S Patel; H A Sinclair; G McAllister
Journal:  Br J Pharmacol       Date:  1994-02       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.